Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junji Furuse

Showing results (141-150 of 348) with videos related to

Pageof 35
Sort By:
American Journal of Clinical Oncology|April 11, 2002
Radiotherapy after transcatheter arterial chemoembolization for patients with hepatocellular carcinoma and portal vein tumor thrombusSatoshi Ishikura, Takashi Ogino, Junji Furuse, et al.
Oncology|December 2, 2005
A phase I study of combination chemotherapy with gemcitabine and oral S-1 for advanced pancreatic cancerHideki Ueno, Takuji Okusaka, Masafumi Ikeda, et al.
Cancer Chemotherapy and Pharmacology|July 2, 2013
A multi-institutional phase II trial of hepatic arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma with portal vein tumor thrombosisMasafumi Ikeda, Takuji Okusaka, Junji Furuse, et al.
Cancer Chemotherapy and Pharmacology|April 10, 2008
A phase II study of S-1 in gemcitabine-refractory metastatic pancreatic cancerChigusa Morizane, Takuji Okusaka, Junji Furuse, et al.
Japanese Journal of Clinical Oncology|March 24, 2017
A Phase I/II trial of continuous hepatic intra-arterial infusion of 5-fluorouracil, mitoxantrone and cisplatin for advanced hepatocellular carcinomaMasafumi Ikeda, Takuji Okusaka, Yozo Sato, et al.
International Journal of Clinical Oncology|October 19, 2025
Efficacy and safety of FOLFOX for Japanese patients with advanced biliary tract cancer as second-line or later chemotherapy (JON2107-B study)Takeshi Terashima, Chigusa Morizane, Akihiko Chida, et al.
Japanese Journal of Clinical Oncology|August 4, 2012
Everolimus for advanced pancreatic neuroendocrine tumours: a subgroup analysis evaluating Japanese patients in the RADIANT-3 trialTetsuhide Ito, Takuji Okusaka, Masafumi Ikeda, et al.
International Journal of Gastrointestinal Cancer|January 13, 2004
The impact of liver metastasis on mortality in patients initially diagnosed with locally advanced or resectable pancreatic cancerChigusa Nakahashi, Tatsuya Oda, Taira Kinoshita, et al.
Annals of Surgical Oncology|July 13, 2023
ASO Author Reflections: Characteristics of Surgery for Biliary Tract Cancer that Should be Considered During the Design of Future Clinical TrialsShin Kobayashi, Masafumi Ikeda, Kohei Nakachi, et al.
Cancer Science|June 15, 2013
Randomized phase II study of gemcitabine plus S-1 versus S-1 in advanced biliary tract cancer: a Japan Clinical Oncology Group trial (JCOG 0805)Chigusa Morizane, Takuji Okusaka, Junki Mizusawa, et al.
Pageof 35

Showing results (141-150 of 348) with videos related to

Sort By:
Pageof 35
American Journal of Clinical Oncology|April 11, 2002
Radiotherapy after transcatheter arterial chemoembolization for patients with hepatocellular carcinoma and portal vein tumor thrombusSatoshi Ishikura, Takashi Ogino, Junji Furuse, et al.
Oncology|December 2, 2005
A phase I study of combination chemotherapy with gemcitabine and oral S-1 for advanced pancreatic cancerHideki Ueno, Takuji Okusaka, Masafumi Ikeda, et al.
Cancer Chemotherapy and Pharmacology|July 2, 2013
A multi-institutional phase II trial of hepatic arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma with portal vein tumor thrombosisMasafumi Ikeda, Takuji Okusaka, Junji Furuse, et al.
Cancer Chemotherapy and Pharmacology|April 10, 2008
A phase II study of S-1 in gemcitabine-refractory metastatic pancreatic cancerChigusa Morizane, Takuji Okusaka, Junji Furuse, et al.
Japanese Journal of Clinical Oncology|March 24, 2017
A Phase I/II trial of continuous hepatic intra-arterial infusion of 5-fluorouracil, mitoxantrone and cisplatin for advanced hepatocellular carcinomaMasafumi Ikeda, Takuji Okusaka, Yozo Sato, et al.
International Journal of Clinical Oncology|October 19, 2025
Efficacy and safety of FOLFOX for Japanese patients with advanced biliary tract cancer as second-line or later chemotherapy (JON2107-B study)Takeshi Terashima, Chigusa Morizane, Akihiko Chida, et al.
Japanese Journal of Clinical Oncology|August 4, 2012
Everolimus for advanced pancreatic neuroendocrine tumours: a subgroup analysis evaluating Japanese patients in the RADIANT-3 trialTetsuhide Ito, Takuji Okusaka, Masafumi Ikeda, et al.
International Journal of Gastrointestinal Cancer|January 13, 2004
The impact of liver metastasis on mortality in patients initially diagnosed with locally advanced or resectable pancreatic cancerChigusa Nakahashi, Tatsuya Oda, Taira Kinoshita, et al.
Annals of Surgical Oncology|July 13, 2023
ASO Author Reflections: Characteristics of Surgery for Biliary Tract Cancer that Should be Considered During the Design of Future Clinical TrialsShin Kobayashi, Masafumi Ikeda, Kohei Nakachi, et al.
Cancer Science|June 15, 2013
Randomized phase II study of gemcitabine plus S-1 versus S-1 in advanced biliary tract cancer: a Japan Clinical Oncology Group trial (JCOG 0805)Chigusa Morizane, Takuji Okusaka, Junki Mizusawa, et al.
Pageof 35